NeuroRx; RELIEF THERAPEUTICS and NeuroRx, Inc. File FDA IND for Aviptadil to Treat COVID-19-induced...
NeuroRx; RELIEF THERAPEUTICS and NeuroRx, Inc. File FDA IND for Aviptadil to Treat COVID-19-induced Respiratory Distress
About this item
Full title
NeuroRx; RELIEF THERAPEUTICS and NeuroRx, Inc. File FDA IND for Aviptadil to Treat COVID-19-induced Respiratory Distress
Publisher
Atlanta: NewsRx
Journal title
Medical Letter on the CDC & FDA, 2020, p.605
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Alternative Titles
Full title
NeuroRx; RELIEF THERAPEUTICS and NeuroRx, Inc. File FDA IND for Aviptadil to Treat COVID-19-induced Respiratory Distress
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_2387514827
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2387514827
Other Identifiers
E-ISSN
1532-4648
How to access this item
Log in as a Library member